Evidence map›Paper›PMID 34349932›Full record

ReviewChemical science2021

By-design molecular architectures

Shaofeng Huang, Zepeng Lei, Yinghua Jin, Wei Zhang

Abstract readReview
In one paragraph

Review in Chemical science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Reactivity of a dAngewandte Chemie (International ed. in English) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Emerging mechanically interlocked cages.Nature reviews. Chemistry · 2025
    Review
  8. Review
  9. Highly Rigid, Yet Conformationally Adaptable, BisporphyrinJournal of the American Chemical Society · 2025
    Article
  10. Article
  11. Article
  12. Metallacyclobutadienes: Intramolecular Rearrangement from Kinetic to Thermodynamic Isomers.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Total Synthesis of Njaoamine C by Concurrent Macrocycle Formation.Journal of the American Chemical Society · 2023
    Article
  17. Review
  18. Article
  19. Selective Para-C-H Alkynylation of Aniline Derivatives by Pd/S,O-Ligand Catalysis.Chemistry (Weinheim an der Bergstrasse, Germany) · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shaofeng HuangDepartment of Chemistry, University of Colorado Boulder 80309 USA wei.zhang@colorado.edu.ORCID https://orcid.org/0000-0002-2565-0005
Zepeng LeiDepartment of Chemistry, University of Colorado Boulder 80309 USA wei.zhang@colorado.edu.ORCID https://orcid.org/0000-0002-8682-8508
Yinghua JinDepartment of Chemistry, University of Colorado Boulder 80309 USA wei.zhang@colorado.edu.ORCID https://orcid.org/0000-0002-8446-8350
Wei ZhangDepartment of Chemistry, University of Colorado Boulder 80309 USA wei.zhang@colorado.edu.ORCID https://orcid.org/0000-0002-5491-1155

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Shape-persistent purely organic molecular architectures have attracted tremendous research interest in the past few decades. Dynamic Covalent Chemistry (DCvC), which deals with reversible covalent bond formation reactions, has emerged as an efficient synthetic approach for constructing these well-defined molecular architectures. Among various dynamic linkages, the formation of ethynylene linkages through dynamic alkyne metathesis is of particular interest due to their high chemical stability, linearity, and rigidity. In this review, we focus on the synthetic strategies of discrete molecular architectures (

Identifiers

PMID34349932
PMCPMC8293811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.